3.2. Association between Immune Responses and Fecal Shedding of Rotavirus among P2-VP8-P[8] Recipients
One month after the third P2-VP8-P[8] vaccine dose, anti-P2-VP8-P[8] IgA seroresponse was higher in shedders (93.3%) compared to non-shedders (69.3%), although this did not reach statistical significance (There were no significant differences between anti-P2-VP8-P[8] IgA, anti-RV IgA or anti-P2-VP8-P[8] IgG antibody titers between vaccinated shedders and non-shedders at baseline or one month after receiving the third P2-VP8-P[8] vaccine (